The aim of our study was to investigate EpCAM‐negative CTCs that were isolated from patients with metastatic breast cancer (mBC) and focus on LKB1 and ZEB1 expression to dissect their functional roles in triggering anoikis and tumor progression. Here, ZEB1 is linked to neoplasm.